Analyst Price Target is GBX 700
▲ +111.80% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Marlowe in the last 3 months. The average price target is GBX 700, with a high forecast of GBX 710 and a low forecast of GBX 690. The average price target represents a 111.80% upside from the last price of GBX 330.50.
Current Consensus is
Buy
The current consensus among 2 investment analysts is to buy stock in Marlowe.
Marlowe is a leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.
Read More
